COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Food profile and its effect on the occurrence of diabetes in patients living with HIV: A cross-sectional study at the Nylon district hospital, Cameroon
- Visualization of nutrient-related clinical practice guidelines in childhood
- Household production and energy content of infant flours for children aged 6 to 11 months in two rural settings in southern Benin
- Anticarcinogenic and antioxidant activities of leaves and flowers hydroalcoholic extracts of Nerium oleander L.: PCA analysis and phytochemical content by FTIR spectroscopy
- Anti-inflammatory activity of doum palm fruit extract used in the management of benign prostatic hyperplasia
- Immune-stimulating and antioxidant properties of a traditional Algerian plant combination: Date fruit (Phoenix dactylifera) and Fenugreek seeds (Trigonella foenum-graecum)
- Prevalence of Peptic Ulcer Disease and Dietary Pattern among Students of a Private University in Nigeria
- Effect of Citric Acid and Brine Pre-Treatment on Deodorization of Green Banana Flour
- Socioeconomic and Demographic Correlates of Nutritional Status in Elderly Urban Dwellers of Havana, Cuba
- Contents
You may also start an advanced similarity search for this article.
NAJFNR is licensed under